ZEN.V - Zentek Ltd.
| Previous Close | 2.1600 |
| Open | 2.1200 |
| Bid | 2.1300 x 0 |
| Ask | 2.1500 x 0 |
| Day's Range | 2.1200 - 2.2000 |
| 52 Week Range | 1.7200 - 3.1700 |
| Volume | |
| Avg. Volume | 34,055 |
| Market Cap | 213.998M |
| Beta (5Y Monthly) | 1.03 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.1800 |
| Earnings Date | Nov 29, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
ACCESSWIREZentek Names Lisa Sim to the Board of Directors
Zentek Ltd.("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), a graphene technology development and commercialization company announces that Ms. Lisa Sim has been appointed to the board of directors of Zentek as an independent director.
- ACCESSWIRE
Zentek and Pattern Energy to Collaborate on Icephobic Technology for Wind Turbine Industry
Zentek Ltd.("Zentek" or the "Company") (Nasdaq:ZTEK)(TSXV:ZEN), a graphene technology development and commercialization company is pleased to announce a collaboration with Pattern Energy Group LP ("Pattern Energy") to optimize, test and validate Zentek's icephobic coating for the wind turbine industry.
- ACCESSWIRE
Zentek Announces Normal Course Issuer Bid
Zentek Ltd.("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), announces that, subject to regulatory approval, it will conduct a normal course issuer bid (the "Bid").
- ACCESSWIRE
Zentek Announces Transfer of the Albany Graphite Project to Subsidiary
Zentek Ltd.("Zentek" or the "Company") (NASDAQ:ZTEK)(TSX-V:ZEN), a graphene technology development and commercialization company is pleased to announce that further to its press release dated April 24, 2023, the Company has completed the transfer of the Albany Graphite Project (as defined below) to its wholly-owned subsidiary, Albany Graphite Corp. ("Albany") pursuant to a Property Purchase Agreement dated April 24, 2023 (the "Agreement").
- ACCESSWIRE
Zentek Receives ISO 13485:2016 Certification
Zentek Ltd.("Zentek" or the "Company") (Nasdaq:ZTEK)(TSXV:ZEN), a graphene technology development and commercialization company has been granted ISO 13485:2016 Quality Management System (QMS) certification standard by British Standards Institution (BSI). The company has also received Medical Device Single Audit Program (MDSAP) certificate # 777967.
- ACCESSWIRE
Zentek Provides Update on Icephobic Technology for Drones
Further to its press release dated September 19, 2022, Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSX-V:ZEN), a graphene technology development and commercialization company, reports successful drone testing, where thrust was maintained under calibrated icing conditions of freezing drizzle and freezing rain in an outdoor, real-world environment.
- ACCESSWIRE
Zentek Provides Review of Albany Graphite
Zentek Ltd.("Zentek" or the "Company") (NASDAQ ZTEK)(TSXV: ZEN), a graphene technology development and commercialization company, further to its press release dated April 25, 2023 announcing the intention to transfer its Albany Graphite Project located north of Lake Superior and southwest of James Bay in Ontario to its currently wholly-owned subsidiary Albany Graphite Corp., provides a review of some of the past testing conducted on the material
- ACCESSWIRE
Zentek Announces Agreement to Transfer Albany Graphite Project to Subsidiary and Intention of Albany Graphite Corp. to Complete a Private Placement Financing
Zentek Ltd.("Zentek" or the "Company") (Nasdaq:ZTEK)(TSXV:ZEN), a graphene technology development and commercialization company is pleased to announce the execution of a property purchase agreement (the "Agreement") with its recently incorporated and currently wholly-owned subsidiary Albany Graphite Corp. ("Albany") to transfer the Albany Graphite Project, and the intention of Albany to complete a non-brokered private placement financing (the "Offering").
- ACCESSWIRE
Zentek Announces Grant of Stock Options
Zentek Ltd.("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), a graphene technology development and commercialization company, announces the granting of 600,000 options to directors, officers and employees of the company exercisable at a price of $2.12 per common share for a period of three to five years from the date of the grant.
- ACCESSWIRE
Zentek Files Patent Applications for ZenGUARD(TM) in Multiple New Jurisdictions
Zentek Ltd.("Zentek" or the "Company") (NASDAQ:ZTEK)(TSX-V:ZEN), a graphene technology development and commercialization company, has filed patent applications for ZenGUARD™ in 47 countries.
- ACCESSWIRE
Zentek Engages Arka BRENStech Pvt Ltd to Develop Opportunities in India
Zentek Ltd.("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV: ZEN), an intellectual property development and commercialization company, has signed an agreement (the "Agreement") with Arka BRENStech Pvt Ltd ("BRENStech"), a company incorporated under the laws of the Republic of India (India), pursuant to which BRENStech will act as a local partner to Zentek as it seeks to develop business opportunities in India.
- ACCESSWIRE
Zentek Announces New Antimicrobial Testing Results
Zentek Ltd.("Zentek" or the "Company") (Nasdaq:ZTEK); (TSXV:ZEN), an intellectual property development and commercialization company, announces that SGS Standard Technical Services Co.
- ACCESSWIRE
Zentek To Participate In The Industrial Tech Virtual Conference Presented By Maxim Group LLC and Hosted by M-Vest
Zentek Ltd.("Zentek" or the "Company") (Nasdaq:ZTEK; TSX-V:ZEN), an intellectual property development and commercialization company, announces its Chief Executive Officer, Greg Fenton, will present at the Industrial Tech Virtual Conference, presented by Maxim Group LLC and hosted by M-Vest, on Tuesday, March 21, 2023. Mr. Fenton will participate in a virtual fireside chat at 2 p.m.
- ACCESSWIRE
Zentek Clarifies Certain Disclosure
Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSXV:ZEN), an intellectual property development and commercialization company, announces that, pursuant to a review by the Ontario Securities Commission (the "OSC") of the Company's continuous disclosure, at the OSC's request, the Company has removed from its website reference to the material resource estimate for the Albany graphite deposit (the "Albany Graphite Deposit") because the technical
- ACCESSWIRE
Zentek and 1329307 BC Ltd. Sign Letter of Intent to Spin Out Albany Graphite Deposit
Zentek Ltd.("Zentek") (NASDAQ:ZTEK)(TSX-V:ZEN), an intellectual property development and commercialization company, and 1329307 BC Ltd. are pleased to announce that they have signed a non-binding letter of intent dated February 13, 2023 (the "LOI"), pursuant to which the parties have agreed to negotiate a transaction (the "Transaction") involving the transfer of Zentek's Albany Graphite Deposit in northern Ontario to an entity ("SpinCo") to be listed
- ACCESSWIRE
Zentek Introduces a Novel Corrosion Protection Technology: ZenARMOR(TM)
Zentek Ltd.("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property development and commercialization company, has developed ZenARMOR™, a novel corrosion protection technology based on functionalized Graphene Oxide (GO) that offers superior performance, self-healing properties and a potential environmental advantage.
- ACCESSWIRE
Zentek Announces Final Results of HVAC Phase 2 Testing
Zentek Ltd.("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property development and commercialization company, is pleased to announce, further to its press releases dated April 11 2022 and December 15, 2022, that it has received the final report for Phase 2 testing of ZenGUARD™ for use in Heating, Ventilation and Air Conditioning ("HVAC") filtration from the National Research Council of Canada ("NRC").
- ACCESSWIRE
Zentek Signs Distribution Agreement with Southmedic Inc.
Zentek Ltd.("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property development and commercialization company, has signed a Distribution Agreement with Southmedic Inc. ("Southmedic") for the distribution of Zentek's patented ZenGUARD™ surgical masks.
- ACCESSWIRE
Zentek Announces Appointment of New Director of Investor Relations
Zentek Ltd.("Zentek" or the "Company") (Nasdaq:ZTEK);(TSXV:ZEN), an intellectual property development and commercialization company, welcomes Mr. Mitch Swergold as its Director of Investor Relations.
- ACCESSWIRE
Zentek Announces Successful Phase 2 Results of HVAC Testing
Zentek Ltd.("Zentek" or the "Company") (NASDAQ:ZTEK)(TSX-V:ZEN), an intellectual property development and commercialization company, reports, further to its press release of April 11, 2022, the successful completion of Phase 2 HVAC filter testing by the National Research Council of Canada ("NRC").
- ACCESSWIRE
Zentek's ZenGUARD(TM) Patent Application Granted by the Canadian Intellectual Property Office
Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property (IP) development and commercialization company, is pleased to announce that on December 6, 2022, it was granted Patent Number 3,152,759 for its ZenGUARD™ technology, "graphene-silver composites and uses for same as an antimicrobial composition."
- ACCESSWIRE
Zentek Files Amended and Restated Audited Financial Statements
Zentek Ltd.("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), announces that it has filed amended and restated audited financial statements (the "Amended and Restated Financials") for the financial year ended March 31, 2022, which amend and restate the previously filed audited financial statements for the financial year ended March 31, 2022 (the "Financial Statements").
- ACCESSWIRE
Zentek Provides Update on Battery Technology Development
Zentek Ltd.("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property development and commercialization company, announces the commencement of a 4-year, $1.6M research project in collaboration with Professors Mohini Sain and Ning Yan from the University of Toronto ("U of T") and Ford Powertrain Engineering Research and Development Centre ("PERDC"). Funding for the project includes $1.2M from the Mitacs Accelerate program. Prof.
- ACCESSWIRE
Zentek to Present ZenGUARD(TM) Technology at the Global Summit on Regulatory Science in Singapore
Zentek Ltd.("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property ("IP") development and commercialization company, is pleased to announce that it was chosen to present the Company's ZenGUARD™ technology at the 12th Annual Global Summit on Regulatory Science on October 19-21, 2022, in the Innovative Nanotechnology Advancement in the Drug and Medical Device track.
- ACCESSWIRE
Zentek Announces Voting Results of Annual and Special Meeting
Zentek Ltd.("Zentek" or the "Company") (Nasdaq:ZTEK)(TSXV:ZEN), an intellectual property development and commercialization company, announces voting results from the annual and special meeting of the Company's shareholders (the "Meeting") held on September 29, 2022. At the Meeting, shareholders voted in favour of all resolutions brought before them.